US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Provident

20.91

+0.07000.34%

Volume:218.34K

Turnover:4.57M

Market Cap:2.73B

PE:9.38

High:21.15

Open:21.03

Low:20.78

Close:20.84

52wk High:23.98

52wk Low:14.34

Shares:130.62M

Float Shares:126.13M

Volume Ratio:0.31

T/O Rate:0.17%

Dividend:0.96

Dividend Rate:4.59%

EPS(TTM):2.23

EPS(LYR):2.23

ROE:10.72%

ROA:1.19%

PB:0.96

PE(LYR):9.37

Loading ...

Overview Company News Filings

What's Behind The Jump In Corcept Therapeutics Stock?

Press Release: BeyondSpring Reports 2025 Year-End Financial Results

Why this buy-rated ASX mining share is tipped to surge 112%

Lomiko’s La Loutre PFS Points to Robust 28-Year Graphite Mine in Quebec

Provident Financial Services names Michael Perito head of investor relations

Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab)

Kalamazoo starts 14,000m infill drilling to advance Mt Olympus PFS

Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Ardea WA nickel project grabs Japanese-US attention

The West Australian

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

Press Release: Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Turaco Gold lifts Afema resource to 4.65Moz as project advances toward PFS

Brightstar drills long high-grade gold intercepts to bolster Sandstone PFS

Unico Silver Reports 143% Mineral Resource Estimate Growth at Argentina Project; Shares Up 3%

MT Newswires Live

Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?

Benzinga_recent_news

CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer

Provident Financial assumed with an Overweight at Piper Sandler

Carnaby Resources' Queensland Project Shows Low-Capex Path to Near-Term Copper Production, Says Euroz Hartleys

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PFS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident","latestPrice":20.91,"timestamp":1774457293635,"preClose":20.84,"halted":0,"volume":218343,"delay":0,"changeRate":0.0033589251439539486,"floatShares":126131374,"shares":130622384,"eps":2.229999,"marketStatus":"Trading","change":0.07,"latestTime":"03-25 12:48:16 EDT","open":21.025,"high":21.15,"low":20.775,"amount":4568089.494003,"amplitude":0.017994,"askPrice":20.92,"askSize":36,"bidPrice":20.91,"bidSize":48,"shortable":3,"etf":0,"ttmEps":2.229999,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1042693200000,"exchange":"NYSE","adjPreClose":20.84,"dividendRate":0.045911,"preHourTrading":{"tag":"盘前","latestPrice":20.989,"preClose":20.84,"latestTime":"08:00 EDT","volume":21,"amount":440.769,"timestamp":1774440006005,"change":0.149,"changeRate":0.00715,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":20.84,"preClose":20.84,"latestTime":"16:20 EDT","volume":22935,"amount":477965.4,"timestamp":1774383600332,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.309801,"impliedVol":0.325,"impliedVolPercentile":0.6135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","floatShares":126131374,"roa":"1.19%","roe":"10.72%","lyrEps":2.231753,"volumeRatio":0.309801,"shares":130622384,"dividePrice":0.96,"high":21.15,"amplitude":0.017994,"preClose":20.84,"low":20.775,"week52Low":14.335,"pbRate":"0.96","psRate":"3.15","week52High":23.9789,"institutionHeld":0.7226,"latestPrice":20.91,"committee":0.142857,"eps":2.229999,"divideRate":0.045911,"volume":218343,"delay":0,"ttmEps":2.229999,"open":21.025,"prevYearClose":19.75,"prevWeekClose":20.29,"prevMonthClose":21.04,"prevQuarterClose":19.75,"fiveDayClose":20.13,"twentyDayClose":21.91,"sixtyDayClose":20.36,"dividendPayoutRate":0.4301551291742411,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.047123599311239044},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFS\",params:#limit:5,,,undefined,":[{"date":"2026-02-13","symbol":"PFS","amount":0.24,"announcedDate":"2026-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-13","defaultRemindTime":1770993000000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-13","currency":"USD","dateTimestamp":1770958800000,"payDate":"2026-02-27"},{"market":"US","date":"2026-01-27","symbol":"PFS","fiscalQuarterEnding":"2025/12","expectedEps":0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1769490000000,"reportTimeType":"post","actualEps":0.64},{"date":"2025-11-14","symbol":"PFS","amount":0.24,"announcedDate":"2025-10-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-11-28"},{"market":"US","date":"2025-10-29","symbol":"PFS","fiscalQuarterEnding":"2025/09","expectedEps":0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"post","actualEps":0.55},{"date":"2025-08-15","symbol":"PFS","amount":0.24,"announcedDate":"2025-07-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-08-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFS\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-05-31","value":0.18,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-31","value":0.18,"currency":"USD"},{"executeDate":"2016-11-10","recordDate":"2016-11-15","paymentDate":"2016-11-30","value":0.18,"currency":"USD"},{"executeDate":"2017-02-13","recordDate":"2017-02-15","paymentDate":"2017-02-28","value":0.19,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-05-31","value":0.19,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1771992000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFS","date":"2026-03-24","current":9.345296,"percent":0.226945,"low":6.410614,"twenty":8.984755,"median":10.56565,"eighty":15.573577,"high":33.979783,"avg":13.051314,"sd":6.392212,"marketCap":2698878305},"quantilePoints":[{"date":"2021-03-26","current":18.002063,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1745317972},{"date":"2021-04-01","current":17.749069,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1720790008},{"date":"2021-04-09","current":18.24715,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1769079438},{"date":"2021-04-16","current":18.405271,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1784409415},{"date":"2021-04-23","current":18.674076,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1810470378},{"date":"2021-04-30","current":14.042944,"twenty":12.721872,"median":16.669814,"eighty":18.884491,"marketCap":1833713567},{"date":"2021-05-07","current":15.049841,"twenty":12.721872,"median":16.625436,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-05-14","current":15.169001,"twenty":12.721872,"median":16.591954,"eighty":18.884491,"marketCap":1980752967},{"date":"2021-05-21","current":15.133253,"twenty":12.721872,"median":16.545238,"eighty":18.884491,"marketCap":1976085049},{"date":"2021-05-28","current":15.049841,"twenty":12.721872,"median":16.529666,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-06-04","current":15.043883,"twenty":12.721872,"median":16.506308,"eighty":18.884491,"marketCap":1964415256},{"date":"2021-06-11","current":14.722153,"twenty":12.721872,"median":16.44402,"eighty":18.884491,"marketCap":1922403999},{"date":"2021-06-18","current":13.679507,"twenty":12.721872,"median":16.40509,"eighty":18.884491,"marketCap":1786256407},{"date":"2021-06-25","current":14.227641,"twenty":12.721872,"median":16.3245,"eighty":18.884491,"marketCap":1857831141},{"date":"2021-07-02","current":13.500768,"twenty":12.721872,"median":16.302281,"eighty":18.884491,"marketCap":1762916819},{"date":"2021-07-09","current":13.244575,"twenty":12.721872,"median":16.261288,"eighty":18.884491,"marketCap":1729463411},{"date":"2021-07-16","current":12.976467,"twenty":12.721872,"median":16.250162,"eighty":18.884491,"marketCap":1694454030},{"date":"2021-07-23","current":12.55345,"twenty":12.69964,"median":16.222063,"eighty":18.884491,"marketCap":1639217007},{"date":"2021-07-30","current":10.433885,"twenty":12.684833,"median":16.184117,"eighty":18.884491,"marketCap":1680450278},{"date":"2021-08-06","current":10.849309,"twenty":12.675728,"median":16.148152,"eighty":18.884491,"marketCap":1747357095},{"date":"2021-08-13","current":10.552042,"twenty":12.660863,"median":16.109223,"eighty":18.884491,"marketCap":1699480276},{"date":"2021-08-20","current":10.381313,"twenty":12.614911,"median":16.079724,"eighty":18.884491,"marketCap":1671983067},{"date":"2021-08-27","current":10.571012,"twenty":12.560516,"median":16.051403,"eighty":18.884491,"marketCap":1702535521},{"date":"2021-09-03","current":10.362343,"twenty":12.528973,"median":16.012247,"eighty":18.884491,"marketCap":1668927821},{"date":"2021-09-10","current":10.43348,"twenty":12.478039,"median":15.976834,"eighty":18.884491,"marketCap":1680384992},{"date":"2021-09-17","current":10.542557,"twenty":12.463634,"median":15.915973,"eighty":18.884491,"marketCap":1697952653},{"date":"2021-09-24","current":10.841334,"twenty":12.367008,"median":15.852207,"eighty":18.884491,"marketCap":1746072768},{"date":"2021-10-01","current":11.315583,"twenty":12.317066,"median":15.827979,"eighty":18.884491,"marketCap":1822453904},{"date":"2021-10-08","current":11.718695,"twenty":12.271397,"median":15.788905,"eighty":18.884491,"marketCap":1887377870},{"date":"2021-10-15","current":11.713953,"twenty":12.250326,"median":15.716295,"eighty":18.884491,"marketCap":1886614059},{"date":"2021-10-22","current":11.808802,"twenty":12.188782,"median":15.680935,"eighty":18.884491,"marketCap":1901890286},{"date":"2021-10-29","current":11.169949,"twenty":12.144658,"median":15.649322,"eighty":18.884491,"marketCap":1912127768},{"date":"2021-11-05","current":11.584988,"twenty":12.022084,"median":15.636232,"eighty":18.884491,"marketCap":1983176134},{"date":"2021-11-12","current":11.413559,"twenty":11.87183,"median":15.555472,"eighty":18.877325,"marketCap":1953830070},{"date":"2021-11-19","current":11.06619,"twenty":11.803248,"median":15.475641,"eighty":18.822017,"marketCap":1894365677},{"date":"2021-11-26","current":10.935362,"twenty":11.752841,"median":15.361209,"eighty":18.799671,"marketCap":1871969996},{"date":"2021-12-03","current":10.660174,"twenty":11.700674,"median":15.25837,"eighty":18.766081,"marketCap":1824861840},{"date":"2021-12-10","current":10.64664,"twenty":11.597269,"median":15.189807,"eighty":18.713257,"marketCap":1822545046},{"date":"2021-12-17","current":10.745888,"twenty":11.515514,"median":15.166494,"eighty":18.654746,"marketCap":1839534872},{"date":"2021-12-23","current":10.957919,"twenty":11.442431,"median":15.126556,"eighty":18.639247,"marketCap":1875831320},{"date":"2021-12-31","current":10.92634,"twenty":11.368446,"median":15.085589,"eighty":18.621596,"marketCap":1870425466},{"date":"2022-01-07","current":11.738372,"twenty":11.326022,"median":15.058778,"eighty":18.579091,"marketCap":2009433139},{"date":"2022-01-14","current":11.729349,"twenty":11.326022,"median":15.040904,"eighty":18.531427,"marketCap":2007888610},{"date":"2022-01-21","current":10.863182,"twenty":11.299875,"median":15.028989,"eighty":18.489553,"marketCap":1859613758},{"date":"2022-01-28","current":11.023748,"twenty":11.261979,"median":15.001772,"eighty":18.453467,"marketCap":1851118845},{"date":"2022-02-04","current":11.088134,"twenty":11.181448,"median":14.930112,"eighty":18.423167,"marketCap":1861930553},{"date":"2022-02-11","current":10.92717,"twenty":11.115728,"median":14.912327,"eighty":18.41438,"marketCap":1834901283},{"date":"2022-02-18","current":10.92717,"twenty":11.065654,"median":14.87528,"eighty":18.386528,"marketCap":1834901283},{"date":"2022-02-25","current":10.732094,"twenty":11.023748,"median":14.820597,"eighty":18.371521,"marketCap":1802143926},{"date":"2022-03-04","current":10.629654,"twenty":11.007105,"median":14.772796,"eighty":18.349914,"marketCap":1784942161},{"date":"2022-03-11","current":10.652348,"twenty":10.957288,"median":14.734826,"eighty":18.315942,"marketCap":1788752883},{"date":"2022-03-18","current":10.806664,"twenty":10.92634,"median":14.709739,"eighty":18.308123,"marketCap":1814665792},{"date":"2022-03-25","current":10.720428,"twenty":10.866543,"median":14.669048,"eighty":18.291682,"marketCap":1800185049},{"date":"2022-04-01","current":10.629654,"twenty":10.847714,"median":14.635382,"eighty":18.253335,"marketCap":1784942161},{"date":"2022-04-08","current":10.053238,"twenty":10.819838,"median":14.583758,"eighty":18.229989,"marketCap":1688149823},{"date":"2022-04-14","current":10.071393,"twenty":10.805336,"median":14.512906,"eighty":18.210171,"marketCap":1691198401},{"date":"2022-04-22","current":10.171245,"twenty":10.764,"median":14.497563,"eighty":18.192392,"marketCap":1707965577},{"date":"2022-04-29","current":10.150722,"twenty":10.733654,"median":14.451873,"eighty":18.177577,"marketCap":1657856535},{"date":"2022-05-06","current":10.297502,"twenty":10.713769,"median":14.383195,"eighty":18.14275,"marketCap":1681829155},{"date":"2022-05-13","current":9.954658,"twenty":10.67461,"median":14.304676,"eighty":18.117189,"marketCap":1625834598},{"date":"2022-05-20","current":10.078233,"twenty":10.650249,"median":14.249341,"eighty":18.096905,"marketCap":1646017372},{"date":"2022-05-27","current":10.572534,"twenty":10.629654,"median":14.193648,"eighty":18.064002,"marketCap":1726748469},{"date":"2022-06-03","current":10.412344,"twenty":10.620376,"median":14.117725,"eighty":18.057139,"marketCap":1700585614},{"date":"2022-06-10","current":10.000427,"twenty":10.605236,"median":13.994542,"eighty":18.016495,"marketCap":1633309699},{"date":"2022-06-17","current":9.92262,"twenty":10.570637,"median":13.872371,"eighty":17.998745,"marketCap":1620602026},{"date":"2022-06-24","current":10.165194,"twenty":10.552314,"median":13.685465,"eighty":17.991294,"marketCap":1660220065},{"date":"2022-07-01","current":10.513034,"twenty":10.530137,"median":13.611721,"eighty":17.968495,"marketCap":1717030837},{"date":"2022-07-08","current":10.31623,"twenty":10.524934,"median":13.456373,"eighty":17.95339,"marketCap":1684887900},{"date":"2022-07-15","current":10.288769,"twenty":10.512341,"median":13.392091,"eighty":17.910649,"marketCap":1680402839},{"date":"2022-07-22","current":10.613725,"twenty":10.505887,"median":13.327225,"eighty":17.849237,"marketCap":1733476061},{"date":"2022-07-29","current":11.467199,"twenty":10.505887,"median":13.302306,"eighty":17.813962,"marketCap":1809111112},{"date":"2022-08-05","current":11.377758,"twenty":10.505887,"median":13.239282,"eighty":17.786291,"marketCap":1795000639},{"date":"2022-08-12","current":11.739288,"twenty":10.505887,"median":13.221695,"eighty":17.762714,"marketCap":1852037025},{"date":"2022-08-19","current":11.748717,"twenty":10.505887,"median":13.209959,"eighty":17.748875,"marketCap":1853524605},{"date":"2022-08-26","current":11.296118,"twenty":10.505887,"median":13.188531,"eighty":17.733901,"marketCap":1782120768},{"date":"2022-09-02","current":10.848234,"twenty":10.505887,"median":13.150076,"eighty":17.684237,"marketCap":1711460720},{"date":"2022-09-09","current":10.928381,"twenty":10.505887,"median":13.130958,"eighty":17.66138,"marketCap":1724105150},{"date":"2022-09-16","current":11.036817,"twenty":10.505887,"median":13.113536,"eighty":17.644475,"marketCap":1741212319},{"date":"2022-09-23","current":10.980242,"twenty":10.505887,"median":13.081395,"eighty":17.623016,"marketCap":1732286840},{"date":"2022-09-30","current":9.193418,"twenty":10.478391,"median":13.065324,"eighty":17.59628,"marketCap":1450390441},{"date":"2022-10-07","current":9.075554,"twenty":10.469523,"median":13.052449,"eighty":17.561143,"marketCap":1431795692},{"date":"2022-10-14","current":9.580013,"twenty":10.437974,"median":13.034632,"eighty":17.546569,"marketCap":1511381219},{"date":"2022-10-21","current":9.716736,"twenty":10.425892,"median":13.011756,"eighty":17.514492,"marketCap":1532951128},{"date":"2022-10-28","current":10.271339,"twenty":10.389888,"median":12.992653,"eighty":17.479985,"marketCap":1683636796},{"date":"2022-11-04","current":10.266754,"twenty":10.377223,"median":12.955005,"eighty":17.444428,"marketCap":1682885173},{"date":"2022-11-11","current":10.291061,"twenty":10.357421,"median":12.934931,"eighty":17.408903,"marketCap":1686869566},{"date":"2022-11-18","current":10.064186,"twenty":10.320716,"median":12.924436,"eighty":17.359105,"marketCap":1649681083},{"date":"2022-11-25","current":10.272911,"twenty":10.310098,"median":12.883192,"eighty":17.323674,"marketCap":1683894487},{"date":"2022-12-02","current":10.204848,"twenty":10.293993,"median":12.857307,"eighty":17.216387,"marketCap":1672737942},{"date":"2022-12-09","current":9.973436,"twenty":10.282719,"median":12.842174,"eighty":17.162345,"marketCap":1634805690},{"date":"2022-12-16","current":9.360873,"twenty":10.269156,"median":12.829982,"eighty":17.036971,"marketCap":1534396787},{"date":"2022-12-23","current":9.719335,"twenty":10.253097,"median":12.811402,"eighty":16.964208,"marketCap":1593154590},{"date":"2022-12-30","current":9.69211,"twenty":10.230259,"median":12.79325,"eighty":16.866633,"marketCap":1588691972},{"date":"2023-01-06","current":9.896298,"twenty":10.216454,"median":12.770698,"eighty":16.761899,"marketCap":1622161606},{"date":"2023-01-13","current":10.150398,"twenty":10.193425,"median":12.743914,"eighty":16.690368,"marketCap":1663812707},{"date":"2023-01-20","current":10.213923,"twenty":10.187062,"median":12.725033,"eighty":16.523587,"marketCap":1674225482},{"date":"2023-01-27","current":9.790009,"twenty":10.173843,"median":12.690346,"eighty":16.324736,"marketCap":1719595430},{"date":"2023-02-03","current":10.396723,"twenty":10.16752,"median":12.677807,"eighty":16.256402,"marketCap":1826163591},{"date":"2023-02-10","current":10.238158,"twenty":10.16752,"median":12.667312,"eighty":16.23143,"marketCap":1798311961},{"date":"2023-02-17","current":10.259586,"twenty":10.15802,"median":12.637027,"eighty":16.127135,"marketCap":1802075695},{"date":"2023-02-24","current":10.011024,"twenty":10.149032,"median":12.580612,"eighty":16.062409,"marketCap":1758416384},{"date":"2023-03-03","current":9.946656,"twenty":10.12732,"median":12.54984,"eighty":16.029311,"marketCap":1747110222},{"date":"2023-03-10","current":8.806492,"twenty":10.110262,"median":12.491259,"eighty":15.99002,"marketCap":1546842669},{"date":"2023-03-17","current":8.551231,"twenty":10.087476,"median":12.467781,"eighty":15.924154,"marketCap":1502006690},{"date":"2023-03-24","current":8.308734,"twenty":10.075497,"median":12.378703,"eighty":15.861307,"marketCap":1459412470},{"date":"2023-03-31","current":8.159832,"twenty":10.060803,"median":12.352386,"eighty":15.839714,"marketCap":1433258125},{"date":"2023-04-06","current":7.704617,"twenty":10.04356,"median":12.287536,"eighty":15.796939,"marketCap":1353300555},{"date":"2023-04-14","current":7.832247,"twenty":10.027135,"median":12.261119,"eighty":15.730693,"marketCap":1375718565},{"date":"2023-04-21","current":7.74716,"twenty":10.017452,"median":12.211348,"eighty":15.694,"marketCap":1360773225},{"date":"2023-04-28","current":7.593207,"twenty":9.999766,"median":12.160062,"eighty":15.664957,"marketCap":1307717267},{"date":"2023-05-05","current":6.573548,"twenty":9.989771,"median":12.09154,"eighty":15.642667,"marketCap":1132109520},{"date":"2023-05-12","current":6.495446,"twenty":9.971621,"median":11.987273,"eighty":15.600987,"marketCap":1118658713},{"date":"2023-05-19","current":7.029498,"twenty":9.961387,"median":11.888242,"eighty":15.530275,"marketCap":1210634281},{"date":"2023-05-26","current":7.046909,"twenty":9.952827,"median":11.808802,"eighty":15.39865,"marketCap":1213632756},{"date":"2023-06-02","current":7.116551,"twenty":9.943684,"median":11.780347,"eighty":15.324881,"marketCap":1225626656},{"date":"2023-06-09","current":7.90873,"twenty":9.929925,"median":11.738372,"eighty":15.203096,"marketCap":1362057268},{"date":"2023-06-16","current":7.934846,"twenty":9.905841,"median":11.713953,"eighty":15.174007,"marketCap":1366554981},{"date":"2023-06-23","current":7.221014,"twenty":9.886325,"median":11.649929,"eighty":15.134319,"marketCap":1243617506},{"date":"2023-06-30","current":7.260188,"twenty":9.866996,"median":11.584988,"eighty":15.109317,"marketCap":1250364075},{"date":"2023-07-07","current":6.946798,"twenty":9.848756,"median":11.548897,"eighty":15.068412,"marketCap":1196391525},{"date":"2023-07-14","current":7.499583,"twenty":9.820363,"median":11.505283,"eighty":15.049841,"marketCap":1291593106},{"date":"2023-07-21","current":8.108951,"twenty":9.78572,"median":11.467199,"eighty":15.032889,"marketCap":1396539731},{"date":"2023-07-28","current":8.682159,"twenty":9.742349,"median":11.428126,"eighty":15.003286,"marketCap":1432521431},{"date":"2023-08-04","current":8.409258,"twenty":9.731294,"median":11.387173,"eighty":14.9415,"marketCap":1387493907},{"date":"2023-08-11","current":8.120111,"twenty":9.718285,"median":11.354912,"eighty":14.916422,"marketCap":1339785831},{"date":"2023-08-18","current":7.624539,"twenty":9.704927,"median":11.300777,"eighty":14.879018,"marketCap":1258018387},{"date":"2023-08-25","current":7.506329,"twenty":9.663774,"median":11.282731,"eighty":14.826043,"marketCap":1238514226},{"date":"2023-09-01","current":7.492689,"twenty":9.624389,"median":11.244446,"eighty":14.781733,"marketCap":1236263745},{"date":"2023-09-08","current":7.310828,"twenty":9.599052,"median":11.197237,"eighty":14.751943,"marketCap":1206257344},{"date":"2023-09-15","current":7.388119,"twenty":9.572255,"median":11.168825,"eighty":14.716388,"marketCap":1219010065},{"date":"2023-09-22","current":6.997117,"twenty":9.538302,"median":11.11225,"eighty":14.678775,"marketCap":1154496301},{"date":"2023-09-29","current":6.951652,"twenty":9.501581,"median":11.06619,"eighty":14.644899,"marketCap":1146994701},{"date":"2023-10-06","current":6.951652,"twenty":9.471361,"median":11.046743,"eighty":14.595078,"marketCap":1146994701},{"date":"2023-10-13","current":6.792523,"twenty":9.431033,"median":11.012054,"eighty":14.515019,"marketCap":1120739099},{"date":"2023-10-20","current":6.542463,"twenty":9.372419,"median":10.980475,"eighty":14.499896,"marketCap":1079480297},{"date":"2023-10-27","current":7.170747,"twenty":9.358917,"median":10.957919,"eighty":14.471655,"marketCap":1076479657},{"date":"2023-11-03","current":7.537213,"twenty":9.227549,"median":10.936586,"eighty":14.399708,"marketCap":1131493992},{"date":"2023-11-10","current":7.179977,"twenty":9.151165,"median":10.92634,"eighty":14.31961,"marketCap":1077865333},{"date":"2023-11-17","current":7.734589,"twenty":9.108811,"median":10.883634,"eighty":14.267749,"marketCap":1161124242},{"date":"2023-11-24","current":7.594687,"twenty":9.078197,"median":10.857,"eighty":14.214839,"marketCap":1140121995},{"date":"2023-12-01","current":7.60468,"twenty":8.976162,"median":10.840069,"eighty":14.143037,"marketCap":1141622155},{"date":"2023-12-08","current":8.214253,"twenty":8.928966,"median":10.82028,"eighty":14.03685,"marketCap":1233131947},{"date":"2023-12-15","current":9.103631,"twenty":8.896863,"median":10.805953,"eighty":13.930523,"marketCap":1366646233},{"date":"2023-12-22","current":9.083645,"twenty":8.896863,"median":10.78687,"eighty":13.759594,"marketCap":1363645912},{"date":"2023-12-29","current":9.223547,"twenty":8.892939,"median":10.761277,"eighty":13.668342,"marketCap":1384648159},{"date":"2024-01-05","current":8.743883,"twenty":8.862382,"median":10.745888,"eighty":13.56351,"marketCap":1312640455},{"date":"2024-01-12","current":8.583995,"twenty":8.806492,"median":10.720428,"eighty":13.408162,"marketCap":1288637886},{"date":"2024-01-19","current":8.309187,"twenty":8.772881,"median":10.697142,"eighty":13.342249,"marketCap":1247383472},{"date":"2024-01-26","current":8.828824,"twenty":8.752732,"median":10.656886,"eighty":13.316627,"marketCap":1325391819},{"date":"2024-02-02","current":9.490046,"twenty":8.752732,"median":10.64215,"eighty":13.30073,"marketCap":1218502920},{"date":"2024-02-09","current":8.830529,"twenty":8.752732,"median":10.629654,"eighty":13.236743,"marketCap":1133822213},{"date":"2024-02-16","current":9.326626,"twenty":8.752732,"median":10.620577,"eighty":13.221244,"marketCap":1197520090},{"date":"2024-02-23","current":8.865547,"twenty":8.752732,"median":10.61055,"eighty":13.209959,"marketCap":1138318534},{"date":"2024-03-01","current":8.801346,"twenty":8.74965,"median":10.589265,"eighty":13.19135,"marketCap":1130075279},{"date":"2024-03-08","current":8.986315,"twenty":8.743883,"median":10.567288,"eighty":13.154274,"marketCap":1153824926},{"date":"2024-03-15","current":8.329352,"twenty":8.723902,"median":10.538449,"eighty":13.128485,"marketCap":1069472190},{"date":"2024-03-22","current":8.96157,"twenty":8.698898,"median":10.5269,"eighty":13.112465,"marketCap":1150647615},{"date":"2024-03-28","current":8.466976,"twenty":8.693607,"median":10.517516,"eighty":13.098537,"marketCap":1087142753},{"date":"2024-04-05","current":8.466976,"twenty":8.653336,"median":10.488954,"eighty":13.065324,"marketCap":1087142753},{"date":"2024-04-12","current":7.990046,"twenty":8.61897,"median":10.476162,"eighty":13.052449,"marketCap":1025905922},{"date":"2024-04-19","current":8.671317,"twenty":8.578848,"median":10.466677,"eighty":13.034632,"marketCap":1040072426},{"date":"2024-04-26","current":9.585747,"twenty":8.579877,"median":10.437517,"eighty":13.020302,"marketCap":1149752791},{"date":"2024-05-03","current":9.605463,"twenty":8.579877,"median":10.431596,"eighty":12.999364,"marketCap":1152117669},{"date":"2024-05-10","current":10.091416,"twenty":8.579877,"median":10.40199,"eighty":12.962642,"marketCap":1210404831},{"date":"2024-05-17","current":10.167149,"twenty":8.579877,"median":10.387579,"eighty":12.944965,"marketCap":1219488545},{"date":"2024-05-24","current":9.554974,"twenty":8.579877,"median":10.368229,"eighty":12.926046,"marketCap":1146061860},{"date":"2024-05-31","current":15.595237,"twenty":8.579877,"median":10.368229,"eighty":12.928956,"marketCap":1870555147},{"date":"2024-06-07","current":14.804645,"twenty":8.579877,"median":10.368229,"eighty":12.944965,"marketCap":1775728393},{"date":"2024-06-14","current":14.479745,"twenty":8.579877,"median":10.368229,"eighty":12.974084,"marketCap":1736758494},{"date":"2024-06-21","current":14.609705,"twenty":8.578848,"median":10.365511,"eighty":13.001042,"marketCap":1752346453},{"date":"2024-06-28","current":15.541087,"twenty":8.578848,"median":10.365511,"eighty":13.028149,"marketCap":1864060164},{"date":"2024-07-05","current":15.400297,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":1847173207},{"date":"2024-07-12","current":17.403852,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":2087487584},{"date":"2024-07-19","current":19.212466,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2304420021},{"date":"2024-07-26","current":32.346496,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2473083727},{"date":"2024-08-02","current":29.436843,"twenty":8.578848,"median":10.365511,"eighty":13.071794,"marketCap":2250623276},{"date":"2024-08-09","current":28.842709,"twenty":8.578848,"median":10.365511,"eighty":13.113823,"marketCap":2205198173},{"date":"2024-08-16","current":30.822445,"twenty":8.578848,"median":10.365511,"eighty":13.134508,"marketCap":2356560887},{"date":"2024-08-23","current":32.631515,"twenty":8.578848,"median":10.365511,"eighty":13.176313,"marketCap":2494875092},{"date":"2024-08-30","current":32.546181,"twenty":8.578848,"median":10.365511,"eighty":13.215944,"marketCap":2488350837},{"date":"2024-09-06","current":31.197913,"twenty":8.578848,"median":10.365511,"eighty":13.228055,"marketCap":2385267609},{"date":"2024-09-13","current":31.300313,"twenty":8.578848,"median":10.365511,"eighty":13.30073,"marketCap":2393096715},{"date":"2024-09-20","current":32.187781,"twenty":8.578848,"median":10.365511,"eighty":13.316627,"marketCap":2460948967},{"date":"2024-09-27","current":31.283246,"twenty":8.578848,"median":10.365511,"eighty":13.405115,"marketCap":2391791864},{"date":"2024-10-04","current":30.429912,"twenty":8.578848,"median":10.365511,"eighty":13.64376,"marketCap":2326549315},{"date":"2024-10-11","current":32.136581,"twenty":8.578848,"median":10.365511,"eighty":13.888037,"marketCap":2457034414},{"date":"2024-10-18","current":33.314182,"twenty":8.578848,"median":10.365511,"eighty":14.144229,"marketCap":2547069132},{"date":"2024-10-25","current":31.88058,"twenty":8.578848,"median":10.365511,"eighty":14.323115,"marketCap":2437461649},{"date":"2024-11-01","current":26.079311,"twenty":8.578848,"median":10.365511,"eighty":14.468915,"marketCap":2459644116},{"date":"2024-11-08","current":29.303632,"twenty":8.578848,"median":10.365511,"eighty":14.501405,"marketCap":2763742765},{"date":"2024-11-15","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.577215,"marketCap":2792450197},{"date":"2024-11-22","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.642195,"marketCap":2792450197},{"date":"2024-11-29","current":29.220619,"twenty":8.578848,"median":10.365511,"eighty":14.720538,"marketCap":2755913466},{"date":"2024-12-06","current":28.72254,"twenty":8.578848,"median":10.365511,"eighty":14.772155,"marketCap":2708937668},{"date":"2024-12-13","current":28.16912,"twenty":8.578848,"median":10.365511,"eighty":14.811522,"marketCap":2656742337},{"date":"2024-12-20","current":26.370502,"twenty":8.578848,"median":10.365511,"eighty":14.879507,"marketCap":2487107512},{"date":"2024-12-27","current":26.107627,"twenty":8.578848,"median":10.365511,"eighty":14.930682,"marketCap":2462314730},{"date":"2025-01-03","current":26.19064,"twenty":8.578848,"median":10.365511,"eighty":15.008136,"marketCap":2470144030},{"date":"2025-01-10","current":24.945443,"twenty":8.578722,"median":10.36461,"eighty":15.045075,"marketCap":2352704535},{"date":"2025-01-17","current":26.730225,"twenty":8.578722,"median":10.36461,"eighty":15.087294,"marketCap":2521034477},{"date":"2025-01-24","current":26.232147,"twenty":8.578722,"median":10.36461,"eighty":15.170193,"marketCap":2474058679},{"date":"2025-01-31","current":20.975271,"twenty":8.578722,"median":10.36461,"eighty":15.27162,"marketCap":2423168232},{"date":"2025-02-07","current":21.686872,"twenty":8.578722,"median":10.36461,"eighty":15.43113,"marketCap":2505375878},{"date":"2025-02-14","current":21.065633,"twenty":8.578722,"median":10.36461,"eighty":15.506431,"marketCap":2433607298},{"date":"2025-02-21","current":20.489576,"twenty":8.578722,"median":10.36461,"eighty":15.601522,"marketCap":2367058251},{"date":"2025-02-28","current":20.614008,"twenty":8.578722,"median":10.36461,"eighty":15.733365,"marketCap":2381433247},{"date":"2025-03-07","current":19.427996,"twenty":8.578596,"median":10.36371,"eighty":15.909803,"marketCap":2244419279},{"date":"2025-03-14","current":19.373214,"twenty":8.58723,"median":10.384564,"eighty":16.110435,"marketCap":2238090520},{"date":"2025-03-21","current":19.113398,"twenty":8.626133,"median":10.390798,"eighty":16.250162,"marketCap":2208075312},{"date":"2025-03-28","current":19.282843,"twenty":8.679674,"median":10.422436,"eighty":16.324736,"marketCap":2227650448},{"date":"2025-04-04","current":17.498022,"twenty":8.697705,"median":10.433885,"eighty":16.538637,"marketCap":2021459018},{"date":"2025-04-11","current":16.594315,"twenty":8.729831,"median":10.450581,"eighty":16.720339,"marketCap":1917058294},{"date":"2025-04-17","current":17.498022,"twenty":8.74788,"median":10.472646,"eighty":16.838352,"marketCap":2021459018},{"date":"2025-04-25","current":14.654875,"twenty":8.784492,"median":10.48224,"eighty":16.926427,"marketCap":2161169063},{"date":"2025-05-02","current":15.142189,"twenty":8.798752,"median":10.513034,"eighty":16.926427,"marketCap":2233033814},{"date":"2025-05-09","current":15.159534,"twenty":8.804878,"median":10.526765,"eighty":16.926427,"marketCap":2235591607},{"date":"2025-05-16","current":15.505075,"twenty":8.82909,"median":10.533858,"eighty":16.926427,"marketCap":2286548985},{"date":"2025-05-23","current":14.787412,"twenty":8.855843,"median":10.556785,"eighty":16.926427,"marketCap":2180714431},{"date":"2025-05-30","current":14.884872,"twenty":8.8606,"median":10.572534,"eighty":16.926427,"marketCap":2195087025},{"date":"2025-06-06","current":14.619071,"twenty":8.875633,"median":10.60779,"eighty":16.926427,"marketCap":2155889043},{"date":"2025-06-13","current":15.000053,"twenty":8.887975,"median":10.619572,"eighty":16.926427,"marketCap":2212072818},{"date":"2025-06-20","current":14.30011,"twenty":8.911603,"median":10.626285,"eighty":16.928687,"marketCap":2108851463},{"date":"2025-06-27","current":15.850617,"twenty":8.946056,"median":10.641658,"eighty":16.928687,"marketCap":2337506362},{"date":"2025-07-03","current":16.710041,"twenty":8.946056,"median":10.65175,"eighty":16.928687,"marketCap":2464246506},{"date":"2025-07-11","current":16.648021,"twenty":8.954399,"median":10.683931,"eighty":16.928687,"marketCap":2455100310},{"date":"2025-07-18","current":16.4974,"twenty":8.954399,"median":10.718159,"eighty":16.928687,"marketCap":2432888120},{"date":"2025-07-25","current":10.379214,"twenty":8.954399,"median":10.725223,"eighty":16.928687,"marketCap":2396954859},{"date":"2025-08-01","current":10.305683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2379973707},{"date":"2025-08-08","current":10.124683,"twenty":8.954399,"median":10.733069,"eighty":16.928687,"marketCap":2338173949},{"date":"2025-08-15","current":10.899581,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2517127428},{"date":"2025-08-22","current":10.633738,"twenty":8.954399,"median":10.730998,"eighty":16.928687,"marketCap":2455734076},{"date":"2025-08-29","current":11.255924,"twenty":8.954399,"median":10.756738,"eighty":16.928687,"marketCap":2599420644},{"date":"2025-09-05","current":11.380362,"twenty":8.954068,"median":10.786944,"eighty":16.930946,"marketCap":2628157958},{"date":"2025-09-12","current":11.312487,"twenty":8.954399,"median":10.806309,"eighty":16.928687,"marketCap":2612483060},{"date":"2025-09-19","current":11.493487,"twenty":8.954399,"median":10.823106,"eighty":16.928687,"marketCap":2654282788},{"date":"2025-09-26","current":11.0523,"twenty":8.984755,"median":10.848771,"eighty":16.928687,"marketCap":2552395949},{"date":"2025-10-03","current":11.018362,"twenty":8.984755,"median":10.865282,"eighty":16.928687,"marketCap":2544558500},{"date":"2025-10-10","current":10.876956,"twenty":8.984755,"median":10.902195,"eighty":16.928687,"marketCap":2511902462},{"date":"2025-10-17","current":10.113363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2335559855},{"date":"2025-10-24","current":10.475363,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2419159313},{"date":"2025-10-31","current":9.425046,"twenty":8.984755,"median":10.905022,"eighty":16.928687,"marketCap":2415196286},{"date":"2025-11-07","current":9.328196,"twenty":8.984755,"median":10.888266,"eighty":16.928687,"marketCap":2390378153},{"date":"2025-11-14","current":9.557624,"twenty":8.984755,"median":10.857,"eighty":16.928687,"marketCap":2449169700},{"date":"2025-11-21","current":9.205903,"twenty":8.984755,"median":10.840069,"eighty":16.928687,"marketCap":2359040255},{"date":"2025-11-28","current":9.812493,"twenty":8.984755,"median":10.820894,"eighty":16.928687,"marketCap":2514480892},{"date":"2025-12-05","current":10.210091,"twenty":8.984755,"median":10.806309,"eighty":16.928687,"marketCap":2616366351},{"date":"2025-12-12","current":10.628077,"twenty":8.984755,"median":10.780942,"eighty":16.928687,"marketCap":2723476706},{"date":"2025-12-19","current":10.801389,"twenty":8.984755,"median":10.756738,"eighty":16.928687,"marketCap":2767888316},{"date":"2025-12-26","current":10.444571,"twenty":8.984755,"median":10.741206,"eighty":16.928687,"marketCap":2676452648},{"date":"2026-01-02","current":10.067363,"twenty":8.984755,"median":10.729963,"eighty":16.928687,"marketCap":2579792084},{"date":"2026-01-09","current":10.3885,"twenty":8.984755,"median":10.718159,"eighty":16.685233,"marketCap":2662084185},{"date":"2026-01-16","current":10.342623,"twenty":8.984755,"median":10.6903,"eighty":16.559093,"marketCap":2650328171},{"date":"2026-01-23","current":10.862558,"twenty":8.984755,"median":10.681432,"eighty":16.43782,"marketCap":2783563003},{"date":"2026-01-30","current":9.968317,"twenty":8.984755,"median":10.656886,"eighty":16.315692,"marketCap":2902375266},{"date":"2026-02-06","current":10.569467,"twenty":8.984755,"median":10.64505,"eighty":16.315692,"marketCap":3077405998},{"date":"2026-02-13","current":10.309268,"twenty":8.984755,"median":10.637462,"eighty":16.315692,"marketCap":3001646428},{"date":"2026-02-20","current":10.295809,"twenty":8.984755,"median":10.627766,"eighty":16.315692,"marketCap":2997727829},{"date":"2026-02-27","current":9.936914,"twenty":8.984755,"median":10.621728,"eighty":16.286003,"marketCap":2893231870},{"date":"2026-03-06","current":9.538728,"twenty":8.984755,"median":10.611113,"eighty":16.080978,"marketCap":2777296077},{"date":"2026-03-13","current":9.157179,"twenty":8.984755,"median":10.607786,"eighty":15.806317,"marketCap":2666204234},{"date":"2026-03-20","current":9.098824,"twenty":8.984755,"median":10.569303,"eighty":15.687592,"marketCap":2649213717},{"date":"2026-03-24","current":9.269399,"twenty":8.984755,"median":10.56565,"eighty":15.573577,"marketCap":2698878305}],"updateTime":1774434700550},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622008723","title":"What's Behind The Jump In Corcept Therapeutics Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622008723","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622008723?lang=en_us&edition=fundamental","pubTime":"2026-03-26 00:06","pubTimestamp":1774454760,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) are soaring Wednesday after the FDA approved a treatment for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/25/Crude-Oil-Price-Hike-Graph-Chart--Stock-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/25/Crude-Oil-Price-Hike-Graph-Chart--Stock-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51461646/whats-behind-the-jump-in-corcept-therapeutics-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51461646/whats-behind-the-jump-in-corcept-therapeutics-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4097","LU0566484027.USD","OS","BK4007","CORT","PFS","BK4211","LU1559883803.SGD","BK4195","BK4532"],"gpt_icon":0},{"id":"2622107545","title":"Press Release: BeyondSpring Reports 2025 Year-End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107545","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622107545?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441800,"startTime":"0","endTime":"0","summary":"-- Phase 3 Survival Benefit Confirmed: Plinabulin combined with docetaxel. standard of care docetaxel in EGFR wild-type NSCLC patients whose tumors. progressed after first line therapy -- DUBLIN-3 study results published. discussions, BeyondSpring is advancing DUBLIN-4, a confirmatory global. Phase 3 study in a biomarker-selected EGFR wild-type NSCLC patient. sensitivity to checkpoint inhibitors -- a significant unmet need. Cell Press journal Med 2025 and presented at SITC 2025. \"2025 was a year of important clinical and operational progress for BeyondSpring and SEED Therapeutics,\" said Dr. Lan Huang, Co-Founder, Chairman and Chief Executive Officer of BeyondSpring. \"We advanced our Phase 3 Plinabulin program, generated meaningful clinical data, and strengthened our strategic and financial position.\". \"BeyondSpring made meaningful progress advancing Plinabulin in Phase 3 NSCLC, while SEED Therapeutics reached a critical milestone -- initiating its first clinical trial following IND cle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","BYSI","PFS","BK4195","BK4225","BK4139","HR","BK4097","BK4203","OS","BK4211"],"gpt_icon":0},{"id":"2622045894","title":"Why this buy-rated ASX mining share is tipped to surge 112%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622045894","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622045894?lang=en_us&edition=fundamental","pubTime":"2026-03-25 10:56","pubTimestamp":1774407416,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index  is highly unlikely to rocket 112% over the next year, but this ASX mining share is forecast to do just that, according to the investment team at Moelis Australia.The potentially money-doubling stock in question is Carnaby Resources Ltd . And that estimate comes atop today's outsized gains.Indeed, Carnaby Resources shares are on fire today.The ASX mining share closed yesterday trading for 36.5 cents. In early afternoon trade on Wednesday, shares are changing hands for 42.5 cents apiece, up 16.4%.We'll look at why Moelis expects that today's gains are just the tip of the iceberg below.Why is the ASX mining share rocketing today?Investors are piling into the ASX mining share today after the company announced new high-grade exploration drill results at Greater Duchess.\"These results are important as they demonstrate the excellent down plunge continuity of the extremely high-grade breccia shoot mineralisation over at least 600 metres below the Ore Reserve Open pit,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/why-this-buy-rated-asx-mining-share-is-tipped-to-surge-112/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/why-this-buy-rated-asx-mining-share-is-tipped-to-surge-112/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","BK4211","XAO.AU","CNB.AU","PFS","BK4195"],"gpt_icon":0},{"id":"2621909644","title":"Lomiko’s La Loutre PFS Points to Robust 28-Year Graphite Mine in Quebec","url":"https://stock-news.laohu8.com/highlight/detail?id=2621909644","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621909644?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:10","pubTimestamp":1774365005,"startTime":"0","endTime":"0","summary":"Lomiko Metals ( ($TSE:LMR) ) has issued an announcement. Lomiko Metals has reported positive preliminary feasibility study results for its La Loutr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lomikos-la-loutre-pfs-points-to-robust-28-year-graphite-mine-in-quebec?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lomikos-la-loutre-pfs-points-to-robust-28-year-graphite-mine-in-quebec?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","PFS","BK4122","PCOM","BK4195"],"gpt_icon":0},{"id":"2621064653","title":"Provident Financial Services names Michael Perito head of investor relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064653?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:02","pubTimestamp":1774353776,"startTime":"0","endTime":"0","summary":"Perito will continue as senior vice president and head of corporate strategy at Provident Bank.Before joining Provident Bank in 2025, Perito was managing director of equity research for banks and financial technology at Keefe, Bruyette & Woods, where he covered more than 30 regional banks and fintech companies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL7mqQrR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0314104364.USD","SG9999014039.USD","IE00B64PRP62.GBP","PFS","NDAQ","BK4112","SG9999014005.SGD","SG9999014013.SGD","SF","IE00BKPKM429.USD","LU2210149790.SGD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BK4211","BK4588","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014021.USD","BK4195","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4127"],"gpt_icon":0},{"id":"2621809037","title":"Prestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621809037","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621809037?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:32","pubTimestamp":1774323120,"startTime":"0","endTime":"0","summary":"Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer. SINGAPORE, March 24, 2026 /PRNewswire/ -- Prestige Biopharma today announced positivetopline results from its Phase 3 SAMSON-II study evaluating HD204, a proposed biosimilar to Avastin  in adult patients with advanced non-squamous non-small cell lung cancer .SAMSON-II is a randomized, double blind, parallel group, multicenter Phase 3 study conducted in 625 patients across 91 centers in 15 countries. Patients were randomized in a 1:1 ratio to receive HD204 or Avastin in combination with standard chemotherapy.\"These results illustrate the increasing precision with which biosimilarity can be established through advanced analytical and clinical PK studies,\" said Dr. Lisa Park, Chief Executive Officer of Prestige Biopharma. \"Our experience with HD204 supports the view that well-designed development programs can reliably anticipate cl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/prestige-biopharma-announces-positive-topline-results-from-comparative-samson-ii-study-for-hd204-a-potential-biosimilar-to-avastin-bevacizumab-302722770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","BK4211","ORR.AU","BK4097","BK4195","BK4218","ORR","BK4007","PK","PFS","OS","BK7095","BK4181"],"gpt_icon":0},{"id":"2621080046","title":"Kalamazoo starts 14,000m infill drilling to advance Mt Olympus PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080046?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:39","pubTimestamp":1774305547,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an announcement. Kalamazoo Resources has launched a major ~14,000-metre infill drilling campaign ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-starts-14000m-infill-drilling-to-advance-mt-olympus-pfs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-starts-14000m-infill-drilling-to-advance-mt-olympus-pfs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","PFS","KZR","BK4195","BK4139"],"gpt_icon":0},{"id":"2621706487","title":"Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706487","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706487?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:45","pubTimestamp":1774269900,"startTime":"0","endTime":"0","summary":"HIGHLIGHTS Formal centralized and independent analysis of the clinical response data from the ACCENT trial has been undertaken and updated analysis provided to the CompanyThe data confirm that five (5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260403/0/en/Amplia-Therapeutics-Reports-Four-Additional-Complete-Responses-and-Improved-Overall-Survival-Data-in-Accent-Pancreatic-Cancer-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4161","BK4097","LENZ","BK4195","BK4139","BK4211","OS","BK4539","INNMF","BK4213","ORR","BK4007","PR","CR"],"gpt_icon":0},{"id":"2621033897","title":"Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2621033897","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621033897?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:00","pubTimestamp":1774267200,"startTime":"0","endTime":"0","summary":"– Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC – – Comb","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260322/0/en/Theriva-Biologics-Announces-Positive-End-of-Phase-2-Meeting-with-U-S-FDA-Regarding-the-Design-of-a-Phase-3-Trial-of-VCN-01-in-Metastatic-Pancreatic-Ductal-Adenocarcinoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OS","BK4588","BK4087","BK4195","BK4081","PFS","EMA","BK4585","BK4211","BK4097","CHMP","LABU"],"gpt_icon":0},{"id":"2621772207","title":"Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621772207","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621772207?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:00","pubTimestamp":1774263600,"startTime":"0","endTime":"0","summary":"- On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma  by end of this month -. - GLIX1 is positioned to potentially address unmet needs for novel and more effective cancer treatments by targeting DNA damage response mechanisms -. - Management to host conference call today, March 23, at 8:30 am EDT -. TEL AVIV, Israel, March 23, 2026 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2025, and provided a corporate update.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX","PFS","BK4567","LU2211817866.USD","IE00BYQQ9H92.USD","ASH","MTD","BK4211","BK4533","LU2413666426.HKD","SCD","IE00BFXG0V08.USD","BK4109","BK4195","LU2413666699.HKD","LU0347712357.USD","BK4585","LU2463526074.USD","LU1721428933.USD","BK4588","BK4121","LU1093756325.SGD","IE00B5TLWC47.USD","BK4139","BK4548","LU1093756168.USD"],"gpt_icon":0},{"id":"2621722924","title":"Ardea WA nickel project grabs Japanese-US attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2621722924","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621722924?lang=en_us&edition=fundamental","pubTime":"2026-03-23 06:07","pubTimestamp":1774217258,"startTime":"0","endTime":"0","summary":"Ardea Resources’ Kalgoorlie nickel project has received a shout-out in the Japan-US Critical Minerals Joint Fact Sheet, a call-to-action to shore up critical mineral supply chains between the two nations.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22035155/0bfaffb4e6d647015d1051897a0997b262d67df2.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22035155/0bfaffb4e6d647015d1051897a0997b262d67df2.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/public-companies/ardea-wa-nickel-project-grabs-japanese-us-attention-c-22035155","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/public-companies/ardea-wa-nickel-project-grabs-japanese-us-attention-c-22035155","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["LU2360107671.USD","BK4166","LU1861220207.SGD","FID.AU","PFS","FID","LU1791807156.HKD","BK4588","LU0106831901.USD","BK4504","DFS","MSP","BK4535","XME","LU1861217088.USD","BK4585","BK4581","BK4211","BK4195","BK4097","EFA","BK7062","LU1668664300.SGD"],"gpt_icon":0},{"id":"2621755198","title":"Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2621755198","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621755198?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:57","pubTimestamp":1774029420,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb shares are experiencing downward pressure. Why is BMY stock retreating?Hodgkin lymphoma  is a cancer in which multinucleated Reed–Sternberg cells  are present in the lymph nodes.Nivolumab received accelerated approval for these indications in 2016 and 2017, respectively.Efficacy of nivolumab in combination with AVD was evaluated in Study CA209-8UT. A total of 994 patients were randomized.The study demonstrated superiority of progression-free survival  in the nivolumab plus AVD arm, with a hazard ratio of 0.42.The median PFS was not reached in either arm, after a median follow-up of 13.7 months.After a median follow-up of 36.7 months, there were 1.8% deaths in the nivolumab plus AVD arm and 3.4% in the brentuximab vedotin plus AVD arm.In 2025, Opdivo generated revenues of $5.9 billion.Earlier in March, the FDA approved Bristol Myers’ oral drug Sotyktu to treat adults with active psoriatic arthritis.BMY Stock Price Activity:Bristol Myers Squibb shares were down1.33%a","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/20/Rueil-malmaison--France---August-13--202.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/20/Rueil-malmaison--France---August-13--202.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/fda/26/03/51387020/bristol-myers-secures-fda-nod-for-opdivo-plus-chemo-for-untreated-hodgkin-lymphoma","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/03/51387020/bristol-myers-secures-fda-nod-for-opdivo-plus-chemo-for-untreated-hodgkin-lymphoma","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU2125154778.USD","LU1868836757.USD","BK4570","LU1032466523.USD","BK4588","LU0985481810.HKD","LU1868836591.USD","LU1093756325.SGD","LU0345780521.USD","IE00BJT1NW94.SGD","BK4581","LU0267386448.USD","BK4211","LU0225284248.USD","LU1670710661.SGD","LU1585245621.USD","LU1868837300.USD","LU0061475181.USD","LU0114720955.EUR","LU1989771016.USD","LU1093756168.USD","BK4007","LABU","LU0868494617.USD","IE00BSNM7G36.USD","LU0321505868.SGD","BK4210","LU0882574055.USD","LU1261432733.SGD","LU1670711123.USD","LU0306807586.USD","LU2133065610.SGD","LU0225771236.USD","LU1718418525.SGD","LU1323610961.USD","MYE","LU0237698245.USD","LU1868837136.USD","BMY","BK4126","BK4585","LU0306806265.USD","IE00BFTCPJ56.SGD","LU0321505439.SGD","LU1291159041.SGD","PFS","LU0345780281.USD","LU1670711040.USD","HL","LU1430594728.SGD"],"gpt_icon":0},{"id":"2620276012","title":"Press Release: Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2620276012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620276012?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:15","pubTimestamp":1773951300,"startTime":"0","endTime":"0","summary":"-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 --. -- Interim systemic lung cancer data with Olvi-Vec demonstrated partial responses in relapsed small cell lung cancer  and early signs of anti-tumor activity in non-small cell lung cancer ; additional updates expected throughout 2026 --. -- Appointed Jason Litten, M.D., as Chief Medical Officer to lead clinical development strategy --. -- $33.1 million in pro forma cash, cash equivalents, marketable securities and restricted cash as of December 31, 2025, including $18.5 million in net proceeds from underwritten offering of common stock in January 2026; expected to support operations into 1Q27--. WESTLAKE VILLAGE, Calif., March 19, 2026  -- Genelux Corporation , a late clinical-stage immuno-oncology company, today announced fourth quarter and full year 2025 financial results and business updates.\"In parallel, we are advancing our manufacturing and operational capabilities to","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNLX","PLTM","BK4139","BK4195","BK4211","PFS"],"gpt_icon":0},{"id":"2620060324","title":"Turaco Gold lifts Afema resource to 4.65Moz as project advances toward PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2620060324","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620060324?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:13","pubTimestamp":1773785589,"startTime":"0","endTime":"0","summary":"Turaco Gold Ltd ( ($AU:TCG) ) has issued an update. Turaco Gold has reported another significant upgrade to the JORC Mineral Resource Estimate at i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/turaco-gold-lifts-afema-resource-to-4-65moz-as-project-advances-toward-pfs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/turaco-gold-lifts-afema-resource-to-4-65moz-as-project-advances-toward-pfs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4195","IAU","SGCmain","159934","GDX","NUGT","GCmain","518880","PFS","DUST","SGUmain","BK4211","MGCmain"],"gpt_icon":0},{"id":"2620069344","title":"Brightstar drills long high-grade gold intercepts to bolster Sandstone PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2620069344","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620069344?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:58","pubTimestamp":1773784710,"startTime":"0","endTime":"0","summary":"Brightstar Resources Limited ( ($AU:BTR) ) has issued an update. Brightstar Resources has reported further strong diamond and reverse circulation d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brightstar-drills-long-high-grade-gold-intercepts-to-bolster-sandstone-pfs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brightstar-drills-long-high-grade-gold-intercepts-to-bolster-sandstone-pfs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","SGOL","DZZ","JNUG","IAU","AAAU","DGP","IAUM","DUST","GDXJ","PFS","XME","BK4207","GDXD","GDX","GLDM","BK4585","BK4588","BK4195","GLL","1OZmain","BK4504","BK4211"],"gpt_icon":0},{"id":"2620415845","title":"Unico Silver Reports 143% Mineral Resource Estimate Growth at Argentina Project; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620415845","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620415845?lang=en_us&edition=fundamental","pubTime":"2026-03-17 08:37","pubTimestamp":1773707853,"startTime":"0","endTime":"0","summary":"Unico Silver  said the mineral resource estimate for its Joaquin Project in Argentina stands at 45.3 million tonnes at 115 grams per tonne silver equivalent  for 167 million ounces AgEq, up 143% in contained AgEq since the project's acquisition in October 2024, according to a Tuesday Australian bourse filing.The company said the mineral resource includes 123 million ounces of silver and 521,000 ounces of gold, with 78% in the high-confidence indicated category, providing a foundation for the upcoming pre-feasibility study .The updated MRE is underpinned by 27,723 meters of drilling completed since April 2025, with an all-in discovery cost of $0.11 per AgEq ounce, per the filing.Combined resources at Joaquin and Cerro Leon now total 76.2 million tonnes at 135 grams per tonne AgEq for 330 million ounces AgEq, including 185 million ounces of silver and 1.1 million ounces of gold, representing a 43% increase since September 2025, the filing added.Total free-milling resources stand at 53.4 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SIL","USL.AU","BK7104","BK4585","PSLV","PFS","XME","BK4588","SIVR","SLVR","BK4547","BK4535","SILJ","BK4195","SLVP","BK4211"],"gpt_icon":1},{"id":"2619462503","title":"Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462503","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462503?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:01","pubTimestamp":1773673260,"startTime":"0","endTime":"0","summary":"Relay Therapeutics shares rise after Phase 3 data show zovegalisib achieved 11.1-month PFS in metastatic breast cancer patients.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/16/doctor--patient--breast-cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/16/doctor--patient--breast-cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51272550/relay-therapeutics-cancer-drug-hits-11-1-month-progression-free-survival-what-does-this-means-for-pretreated-breast-cancer-patients","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51272550/relay-therapeutics-cancer-drug-hits-11-1-month-progression-free-survival-what-does-this-means-for-pretreated-breast-cancer-patients","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","PFS","RLAY","BK4139","BK4211","BK4563","BK4195","SMA"],"gpt_icon":0},{"id":"2619269450","title":"CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2619269450","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619269450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:00","pubTimestamp":1773658800,"startTime":"0","endTime":"0","summary":"- Confirmed response rates in expansion cohorts of32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W - - Estimated progression free survival of 7.1 months at 10 mg/kg and 6.8 months at 8.6 mg/kg - - Gr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/16/3256138/37704/en/CytomX-s-Varsetatug-Masetecan-EpCAM-PROBODY-ADC-Continues-to-Demonstrate-Positive-Data-Supporting-Potential-as-a-New-Treatment-Option-in-Late-Line-Colorectal-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4080","BK4231","TRAE","BK4213","LU0456854461.SGD","CRC","LU0266512127.USD","PFS","ADC","BK4211","ORR"],"gpt_icon":0},{"id":"2619617452","title":"Provident Financial assumed with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2619617452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619617452?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:50","pubTimestamp":1773658245,"startTime":"0","endTime":"0","summary":"Piper Sandler assumed coverage of Provident Financial (PFS) with an Overweight rating and $25 price target The firm’s bullish thesis is based on co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/provident-financial-assumed-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/provident-financial-assumed-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PFS","BK4195","BK4211"],"gpt_icon":0},{"id":"2619369684","title":"Carnaby Resources' Queensland Project Shows Low-Capex Path to Near-Term Copper Production, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2619369684","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619369684?lang=en_us&edition=fundamental","pubTime":"2026-03-16 12:56","pubTimestamp":1773636980,"startTime":"0","endTime":"0","summary":"Carnaby Resources  delivered a pre-feasibility study  for its Great Duchess copper-gold project that highlights low capital expenditure, solid free cash flow  potential, and a near-term pathway to production, said Euroz Hartleys in a Monday note.The PFS includes the Trekelano project and showed a maiden ore reserve of 8.4million tonnes with a grade of 1.9% copper equivalent, evenly divided between open-pit and underground deposits.The company plans to produce 17,000 tonnes of copper equivalent per year over eight years at an all-in sustaining cost of AU$4.35 per pound, with capital expenditures of AU$24million and post-tax FCF around AU$50million.The firm noted that with a market capitalization of around AU$120million, the company is a near-term copper developer leveraging existing infrastructure.The firm highlighted strong exploration potential at the Trek-1 and Trek-2 deposits, which remain open at depth, and warned that the company could be a takeover target if the market overlooks ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CPXR","CPER","QCmain","BK4195","BK4585","BK4588","BK4535","COPX","BK4211","BK7095","CNB.AU","XME","FCF","PFS","MHGmain","COPJ"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}